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Influence of Diaphragmatic Mobility on Hypercapnia in Patients 
with Chronic Obstructive Pulmonary Disease
A reduction in diaphragm mobility has been identified in patients with chronic obstructive 
pulmonary disease (COPD) and has been associated with a decline in pulmonary function 
parameters. However, little information exists regarding the potential role of diaphragm 
mobility on hypercapnia in COPD. A new method of assessing the mobility of the 
diaphragm, using ultrasound, has recently been validated. The purpose of the present 
study was to investigate the relationship between diaphragm mobility and pulmonary 
function parameters, as well as that between arterial blood gas values and diaphragm 
mobility, in COPD patients. Thirty seven COPD patients were recruited for pulmonary 
function test, arterial blood gas analysis and diaphragm mobility using ultrasound to 
measure the craniocaudal displacement of the left branch of the portal vein. There were 
significant negative correlations between diaphragmatic mobility and PaCO2 (r = -0.373, 
P = 0.030). Diaphragmatic mobility correlated with airway obstruction (FEV1, r = 0.415, 
P = 0.011) and with ventilatory capacity (FVC, r = 0.302, P = 0.029; MVV, r = 0.481, 
P = 0.003). Diaphragmatic mobility also correlated significantly with pulmonary 
hyperinflation. No relationship was observed between diaphragm mobility and PaO2 (r = 
-0.028, P = 0.873). These findings support a possibility that the reduction in diaphragm 
mobility relates to hypercapnia in COPD patients.
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Respiratory Diseases
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is character-
ized by airflow limitation that is not fully reversible and abnor-
mal inflammatory response of the lungs to noxious particles or 
gases (1). A number of pathophysiological mechanisms of COPD 
such as airway obstruction, pulmonary hyperinflation and air 
trapping, might be involved in this process of impairment of di-
aphragmatic function (2). 
  The respiratory muscles constitute a vital component of the 
respiratory pump. Their contraction during part of the breath-
ing cycle changes the anatomic configuration of the thorax and 
displaces its components, so that air moves into and out of the 
gas exchanging portion of the lungs (3, 4). Diaphragm is the prin-
cipal generator of tidal volume in normal subjects at rest. Studies 
have shown that the impairment of diaphragm mobility might 
be associated with alterations in the principal pulmonary func-
tion parameters (5, 6). Several methods are used to quantify the 
diaphragmatic mobility using chest radiographs (7), computed 
tomography scan (8), and dynamic magnetic resonance imag-
ing (9). Radiological evaluation of diaphragm mobility has tra-
ditionally been performed through fluoroscopy (10), but recent-
ly ultrasound measurement of the craniocaudal displacement 
of the left branch of the portal vein has validated as a new meth-
od for assessing diaphragm mobility (11). Ultrasonography has 
several advantages over fluoroscopy, including lack of risk from 
ionizing radiation, equipment portability, and direct quantita-
tive information (12).
  The mechanisms which lead to chronic hypercapnia in pa-
tients with COPD are not completely understood. Several fac-
tors such as airway obstruction, ventilation-perfusion mismatch, 
abnormalities in ventilatory control, respiratory muscle weak-
ness, the pattern of breathing, and dynamic pulmonary hyper-
inflation have been reported to contribute to chronic carbon 
dioxide retention in patients with COPD (13-15). To our knowl-
edge, there are few reports available concerning the relationships 
between the diaphragm mobility and hypercapnia in patients 
with COPD. Therefore, the purpose of this study was designed 
to investigate the relationship between diaphragm mobility and 
pulmonary function parameters, as well as that between arteri-
al blood gas values and diaphragm mobility, in COPD patients.
 
MATERIALS AND METHODS
Subjects
Patient with a diagnosis of COPD, determined according to the Kang HW, et al.  •  Diaphragmatic Mobility on Hypercapnia in COPD
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American Thoracic Society (ATS) guidelines (1), were recruited 
from January to December 2010 in the study. The inclusion cri-
teria were a history of smoking, an FEV1 (forced expiratory vol-
ume in 1 second)/FVC (forced vital capacity) ratio < 70%, and 
an FEV1 < 80% of the predicted values. Exclusion criteria were 
respiratory disorders other than COPD, pulmonary embolism, 
infectious diseases, malignancy, left ventricular dysfunction, 
recent surgery, and severe endocrine, hepatic, or renal diseases. 
All patients were clinically stable COPD with no exacerbation of 
symptoms and no hospitalization with the preceding 2 months. 
At recruitment, height and weight were measured and the body 
mass index (BMI) was calculated (weight [kg]/height [m
2]). 
Pulmonary function test
All pulmonary function tests were evaluated using a Sensormed-
ics 2400 Unit (Sensormedics; San Diego, CA, USA) that met the 
standards of the ATS (1). Most pulmonary function tests were 
obtained on the same day as the ultrasonography and/or arte-
rial blood gas analysis. Three technically acceptable measure-
ments were performed in each patient, and highest one was in-
cluded to the analyses. Acceptable maneuvers were defined as 
those with sharp peak in the flow curve and an expiratory dura-
tion greater than six seconds. FEV1, FVC, and lung volume were 
expressed as percentage of predicted values.
Arterial blood gas analysis 
Arterial blood samples taken with the patients at rest and breath-
ing room air were analyzed for oxygen (PaO2), carbon dioxide 
tension (PaCO2), and pH with a standard blood gas analyzer (Ra-
diometer ABL 700 Series; Kopenhagen, Denmark). 
Diaphragm mobility
Assessment of the mobility of the right hemidiaphragm was per-
formed by ultrasound measurement of the craniocaudal dis-
placement of the left branch of the portal vein, using an ultra-
sound scanner (ALOKA KEC-620; Tokyo, Japan) in mode B (16). 
All evaluations were made by the same pulmonologist who was 
blinded to the pulmonary function status of each patient. The 
patients were evaluated in the dorsal decubitus position, using 
a 3.5-MHz convex transducer positioned over the right subcos-
tal region, at an angle of incidence perpendicular to the cranio-
caudal axis. The position of the left branch was then demarcat-
ed with the cursor during forced expiration and inspiration. The 
mobility of the right hemidiaphragm was defined as the cranio-
caudal displacement of this branch, in millimeters (Fig. 1). Three 
measurements were recorded for each patient, and the greatest 
value was used for analysis.
Statistical analysis
A statistical software package (SPSS, version 18.0; SPSS Inc; Chi-
cago, IL, USA) was used for all statistical analyses. The data are 
reported as mean ± standard deviation. Correlations between 
diaphragmatic mobility and other parameters were assessed 
using Spearman’s correlation test. A P value less than 0.05 was 
considered statistically significant.
Ethics statement
This study protocol was approved by the institutional review 
boards of Chonnam National University Hospital (CRI09047-1). 
All subjects provided written informed consent before partici-
pation.
RESULTS
The 37 patients with COPD (31 male and 6 female) were partici-
pated in this study. The mean age of the patients was 69.1 ± 9.0 
Table 1. Clinical characteristics and pulmonary function values of the subject studied
Variables Observed values
Gender
   Male
   Female
 
31
  6
Age (yr) 69.1 ± 9.0
BMI (kg/m
2) 21.2 ± 4.1
Smoking history (pack-years)   30.7 ± 32.2
FEV1 (% predicted)   49.9 ± 26.1
FVC (% predicted)   69.1 ± 21.5
FEV1/FVC ratio (%)   48.4 ± 15.7
RV (% predicted) 145.7 ± 29.7
TLC (% predicted) 119.4 ± 26.5
MVV (L/min)   38.5 ± 21.5
Diaphragm mobility (mm) 19.8 ± 7.5
Data are expressed as mean ± standard deviation. BMI, body mass index; FEV1, forced 
expiratory volume in 1 second; FVC, forced vital capacity; RV, residual volume; TLC, 
total lung capacity; MVV, maximal voluntary ventilation.
Fig. 1. B-mode ultrasonography measurement of craniocaudal displacement of the 
left intrahepatic portal vein branch. The line shows displacement of the left branch of 
the portal vein during maximal inspiratory and expiratory breathing in the sagittal plane. 
The P cursor marks the initial position of this vessel during maximal expiration, and 
another cursor (+) marks the position of the vessel during maximal inspiration. The 
craniocaudal displacement of this branch was recorded in millimeters.
Expiration
P +
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yr, and the mean BMI was 21.2 ± 4.1 kg/m
2. All patients present-
ed airflow limitation (mean FEV1/FVC, 48.4% ± 15.7%) and pul-
monary hyperinflation (mean total lung capacity [TLC], 119.4% 
± 26.5% of predicted; mean residual volume [RV], 145.7% ± 29.7% 
of predicted) (Table 1).
  The mean values of diaphragmatic mobility were 19.8 ± 7.5 
mm, and the mean PaCO2 was 45.2 ± 16.0 mmHg. There were 
significant negative correlations between the diaphragm mobil-
ity and PaCO2 in patients with COPD (r = -0.373, P = 0.030) (Fig. 
2). However, there was no correlation between diaphragm mo-
bility and PaO2 (r = 0.028, P = 0.873).
  Diaphragm mobility correlated with the pulmonary function 
parameters that quantify airway obstruction (FEV1: r = 0.415, P = 
0.011) and pulmonary hyperinflation (RV: r = -0.501, P = 0.021; 
TLC: r = -0.281, P = 0.030; RV/TLC: r = -0.527, P = 0.001). Dia-
phragmatic mobility also correlated significantly with ventilator 
capacity (FVC: r = 0.302, P = 0.029; MVV: r = 0.481, P = 0.003). 
However, there was no correlation between diaphragm mobili-
ty and FEV1/FVC (r = 0.233, P = 0.166) (Table 2). In the multivar-
iate analyses, PaCO2 and RV/TLC were independent factors for 
the diaphragm mobility.
DISCUSSION
The present study has shown that COPD patients with reduction 
in diaphragmatic mobility are associated with PaCO2 values. In 
addition, our result show that reduced diaphragmatic mobility 
is associated with airway obstruction and pulmonary hyperin-
flation.
  Expiratory flow limitation is the pathophysiological hallmark 
of COPD. The disease is associated with systemic manifestations 
that can result in worsening dyspnea, impaired functional ca-
pacity, reduced healthy-related quality of life and increased mor-
tality. Dyspnea could result from a decreased capacity of the re-
spiratory muscle to meet an increased mechanical load. In ad-
dition, COPD patients commonly present increased airflow re-
sistance as well as air trapping and pulmonary hyperinflation. 
Pulmonary hyperinflation reduces the flow and pressure-gen-
erating capacity of the diaphragm (17). As COPD patients devel-
op hyperinflation, their diaphragm becomes flatter and shorter. 
COPD patients have decreased diaphragm mobility when com-
pared with healthy humans (6, 9). The reduced diaphragmatic 
mobility observed in COPD patients might be attributable to ex-
cessive actin–myosin filament overlap and sarcomere remodel-
ing (18, 19). The main cause of the reduction in diaphragmatic 
mobility is shortening of the apposition zone resulting from the 
absence of the piston-like movement of the diaphragm (20). A 
recent study demonstrated that reduction in diaphragm mobil-
ity correlated with airway obstruction, pulmonary hyperinfla-
tion and ventilator capacity (5). These findings are consistency 
with our results showing that diaphragm mobility is positively 
correlated with airway obstruction and ventilator capacity. Re-
duction in diaphragm mobility in patients with COPD is nega-
tively correlated with pulmonary function parameters related 
to lung hyperinflation. Although FEV1 is essential to diagnosis 
and quantifying COPD-related ventilator impairment (1), it does 
not adequately reflect the systemic manifestation of COPD (21). 
Therefore, it has been proposed that other parameters should 
be evaluated in order to measure changes in the functional sta-
tus of COPD patients. The results of the present study suggest 
that diaphragmatic mobility is another parameter that could 
provide information on respiratory mechanics and functional 
capacity in COPD patients.
  Several factors such as airway obstruction, ventilation-perfu-
sion mismatch, abnormalities in ventilatory control, respiratory 
muscle weakness, pattern of breathing, and dynamic pulmo-
nary hyperinflation have been reported to contribute to carbon 
dioxide retention in patients with COPD (13-15). A previous study 
demonstrated that hypercapnia increases with the severity of 
the obstruction, obesity, and inspiratory muscle weakness (22). 
Hypercapnic respiratory failure due to inspiratory muscle weak-
ness is associated with morbidity in patients with COPD (23). 
Table 2. Correlation between diaphragm mobility with pulmonary function variables
Variables Linear correlation  
coefficient (r-value) P value
FEV1 (% predicted) 0.415  0.011
FVC (% predicted) 0.302  0.029
FEV1/FVC ratio (%) 0.233  0.166
RV (% predicted) -0.501  0.021
TLC (% predicted) -0.281  0.030
RV/TLC (%) -0.527  0.001
MVV (L/min) 0.481  0.003
Fig. 2. The relationship between diaphragmatic mobility and the PaCO2. There was a 
negative linear correlation between the two measurements (r = -0.373, P = 0.030). 
PaCO2, arterial carbon dioxide tension.
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Rapid and shallow breathing in patients with COPD is the con-
sequence of an excessive load imposed on the inspiratory mus-
cles. The shallow breathing reduces alveolar ventilation and pre-
disposes to hypercapnia. A study demonstrated that, in patients 
with stable COPD, PaCO2 was significantly related to positive end 
expiratory alveolar pressure which suggests that dynamic pul-
monary hyperinflation could play a part in chronic carbon diox-
ide retention (24). To our knowledge, however, no previous stud-
ies have specifically examined the correlations between dia-
phragm mobility and PaCO2 values. Our results show that sig-
nificant negative correlations between the diaphragm mobility 
and PaCO2 levels in patients with COPD. 
  In conclusion, ultrasonography was used to determine the 
diaphragm mobility in this study. Our study demonstrates that 
the reduction of diaphragm mobility in patients with COPD is 
associated with carbon dioxide retention. In addition, diaphrag-
matic mobility correlates with airway obstruction, ventilatory 
capacity and pulmonary hyperinflation. These findings support 
a possibility that the reduction in diaphragm mobility relates to 
hypercapnia in COPD patients. Further studies are required to 
better understand the diaphragm mobility on hypercapnia in 
patients with COPD.
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A reduction in diaphragm mobility has been identified in patients with chronic obstructive pulmonary disease (COPD) and has been 
associated with a decline in pulmonary function parameters. However, little information exists regarding the potential role of 
diaphragm mobility on hypercapnia in COPD. We investigated the relationship between diaphragm mobility and arterial blood gas 
values in COPD patients. There were significant negative correlations between diaphragmatic mobility and PaCO2. Also, 
diaphragmatic mobility correlated with airway obstruction, ventilatory capacity and hyperinflation of lungs. 